What is the Buying Price of Emcure Pharmaceuticals Share?

The Buying Price of Emcure Pharmaceuticals share is 1710.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Emcure Pharmaceuticals Share at Choice?

To buy Emcure Pharmaceuticals stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Emcure Pharmaceuticals, choose your preferred order type, and place the trade.

What is the PE ratio of Emcure Pharmaceuticals Shares?

The Price-to-earnings (P/E) ratio of Emcure Pharmaceuticals shares is 34.98. You can compare it with the sector average for relative valuation.

What is the PB ratio of Emcure Pharmaceuticals Shares?

The Price to Book (P/B) ratio Emcure Pharmaceuticals shares is 6.53. Useful to assess the stock's value relative to its book value.

Is Emcure Pharmaceuticals Overvalued?

To assess Emcure Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Emcure Pharmaceuticals?

The Market Cap of Emcure Pharmaceuticals is 32313.64 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Emcure Pharmaceuticals Share Price?

The 52 week high and low prices of Emcure Pharmaceuticals share price is 1830 & 1228.9. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Emcure Pharmaceuticals belong to?

Emcure Pharmaceuticals belongs to the Healthcare sector.

Emcure Pharmaceuticals Share price

EMCURE

Healthcare Large Cap

1710.5

6.10 (0.36%)

NSE

BSE

Last updated on 3 Jun, 2026 | 09:16 IST

BUYSELL

Today's High

1718.00

Today's Low

1706.00

52 Week Low

1228.90

52 Week High

1830.00

Free Demat with Zero AMC*

Emcure Pharmaceuticals Chart

ChartIQ

TradingView

Emcure Pharmaceuticals Share Key Metrics

Volume

415.00 Market Cap

32313.64 CR

LTQ@LTP

13@1710.50

ATP

1713.36

Var Margin

17.45 %

Circuit Range

1534-1874.8

Delivery %

63.43 %

Value

7.11 L

ASM/GSM

No

Market Lot

1

Summary

3 Jun, 2026 | 09:16 को, Emcure Pharmaceuticals का शेयर प्राइस आज ₹1710.5 पर है, जो दिन के लिए 6.10% की 0.36 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1706.00 और ₹1718.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1228.90 से ₹1830.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Emcure Pharmaceuticals ने 415 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹189589547 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹171336 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 13,171050 रही। यह स्टॉक ₹1534-1874.8 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹7.11 L है। दिन के लिए डिलीवरी परसेंटेज 63.43% रही। इसके अतिरिक्त, Emcure Pharmaceuticals वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Emcure Pharmaceuticals Fundamentals

P/E Ratio

34.98

P/B Ratio

6.53

Div. Yield

0.21

Sector P/E

69.94

Sector P/B

2.97

Sec. Div. Yield

0.55

Emcure Pharmaceuticals Resistance and Support

Pivot 1695.03

Resistance

First Resistance

1723.06

Second Resistance

1741.73

Third Resistance

1769.76

Support

First Support

1676.36

Second Support

1648.33

Third Support

1629.66

Emcure Pharmaceuticals Shareholding Pattern

2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

77.94%

Mutual Fund

3.1%

Insurance

0.36%

Foreign Institutional Investors

3.05%

Domestic Institutional Investors

0.41%

Retail

15.14%

Others

0%

Total Promoters

SEP '24

78.08%

DEC '24

77.94%

Emcure Pharmaceuticals Corporate Actions

Date	Agenda
2026-05-05	Audited Results & Final Dividend
2026-02-04	Quarterly Results

Emcure Pharmaceuticals News

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Emcure Pharmaceuticals is scheduled to participate in four investor conferences in Mumbai from May 26 to June 09, 2026. The company will engage with institutional investors from Ambit Capital, 360 ONE Capital, Axis Capital, and ICICI Securities.

May 20 2026 16:55:14

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Emcure Pharmaceuticals is scheduled to participate in four investor conferences in Mumbai from May 26 to June 09, 2026. The company will engage with institutional investors from Ambit Capital, 360 ONE Capital, Axis Capital, and ICICI Securities.

May 20 2026 16:51:37

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Emcure Pharmaceuticals is scheduled to participate in four investor conferences in Mumbai from May 26 to June 09, 2026. The company will engage with institutional investors from Ambit Capital, 360 ONE Capital, Axis Capital, and ICICI Securities.

May 20 2026 16:49:55

Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals received a Form 483 with 7 observations from the US FDA following an inspection at its Sanand formulations facility. The company stated the observations are procedural and will be addressed.

May 16 2026 14:57:10

Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - US FDA Inspection At Our Formulations Facility Located At Sanand, Ahmedabad, Gujarat, India.

Emcure Pharma received a Form 483 with 7 procedural observations from the US FDA following an inspection at its Sanand formulations facility from May 6 to May 15, 2026. The company will address these observations and respond to the FDA within the stipulated timeframe.

May 16 2026 14:49:06

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Emcure Pharmaceuticals Ltd reported strong FY26 performance, surpassing $1 billion in revenue with 16.6% YoY growth. The company projects low to mid-teen revenue growth and 75-100 bps EBITDA margin expansion for FY27.

May 11 2026 18:16:06

Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating

Emcure Pharmaceuticals announced it received an ESG rating of 21 from NSE Sustainability Ratings & Analytics for FY2024-25. This rating was voluntarily and independently assigned.

May 08 2026 13:13:17

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Emcure Pharmaceuticals has made the audio recording of its Q4 FY26 earnings call, held on May 05, 2026, available on its website. This provides investors access to the discussion details from the call.

May 05 2026 20:18:33

Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Ltd. board has recommended a final dividend of Re 0.36 per equity share for the financial year 2025-26. This dividend is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM). The record date and AGM date will be announced later.

May 05 2026 18:03:14

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management

Emcure Pharmaceuticals re-appointed Mr. Satish Mehta as Managing Director for 5 years and Dr. Mukund Gurjar as Whole-time Director for 1 year. Both re-appointments are effective from August 2026 and April 2027 respectively, subject to shareholder approval.

May 05 2026 15:46:26

Name	Position
Berjis Desai	Chairman
Satish Mehta	Managing Director & Chief Executive Officer

Emcure Pharmaceuticals Similar Stocks

Glaxosmithkline Pharmaceuticals Ltd.

2182.70

-6.10 (0.28%)

Ajanta Pharma Ltd.

2898.90

-13.30 (0.46%)

Wockhardt Ltd.

2002.90

36.70 (1.87%)

JB Chemicals & Pharmaceuticals Ltd.

2114.90

-14.70 (0.69%)

Global Health Ltd.

1209.00

10.20 (0.85%)

Krishna Institute of Medical Sciences Ltd

741.60

-4.80 (0.64%)

Dr. Lal Pathlabs Ltd.

1574.10

13.10 (0.84%)

Acutaas Chemicals Ltd.

3064.30

26.70 (0.88%)

Sai Life Sciences Ltd.

1115.00

-13.30 (1.18%)

Emcure Pharmaceuticals FAQs

Emcure Pharmaceuticals शेयर का खरीद मूल्य 1710.5 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Emcure Pharmaceuticals शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Emcure Pharmaceuticals शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 34.98 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Emcure Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 6.53 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Emcure Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.97 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Emcure Pharmaceuticals का मार्केट कैप 32313.64 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Emcure Pharmaceuticals शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1830.00 और 1228.90 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।